Pages that link to "Q77512319"

The following pages link to CD83+ blood dendritic cells as a vaccine for immunotherapy of metastatic renal-cell cancer (Q77512319):

Displaying 21 items.

• Generation in vitro of B-cell chronic lymphocytic leukaemia-proliferative and specific HLA class-II-restricted cytotoxic T-cell responses using autologous dendritic cells pulsed with tumour cell lysate (Q28362580) (← links)
• Cancer immunotherapy: synthetic and natural peptides in the balance. (Q33740203) (← links)
• Keyhole limpet hemocyanin (KLH): a biomedical review (Q33764096) (← links)
• Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells (Q34103579) (← links)
• Dendritic cell vaccination for cancer therapy (Q34293614) (← links)
• An optimized method for manufacturing a clinical scale dendritic cell-based vaccine for the treatment of glioblastoma (Q34533616) (← links)
• The use of dendritic cells in cancer therapy (Q34571978) (← links)
• Rapid antibody responses by low-dose, single-step, dendritic cell-targeted immunization (Q34979735) (← links)
• Dendritic cell vaccination: new hope for the treatment of metastasized endocrine malignancies (Q35114583) (← links)
• An Escherichia coli-based oral vaccine against urinary tract infections potently activates human dendritic cells (Q40630456) (← links)
• Phase IB study of 25-hydroxyvitamin D(3) treatment to diminish suppressor cells in head and neck cancer patients (Q43796406) (← links)
• A clinically approved oral vaccine against pneumotropic bacteria induces the terminal maturation of CD83+ immunostimulatory dendritic cells. (Q44335067) (← links)
• Allogeneic Dendritic Cells Fused with Tumor Cells: Preclinical Results and Outcome of a Clinical Phase I/II Trial in Patients with Metastatic Renal Cell Carcinoma (Q47978606) (← links)
• Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial. (Q64903075) (← links)
• [Adoptive immunotherapy: evaluation and perspectives in the treatment of certain cancers] (Q73182177) (← links)
• Report from the International Union Against Cancer (UICC) Tumor Biology Committee: UICC workshop on the use of dendritic cells in cancer clinical trials (Q73265616) (← links)
• Extensive characterization of dendritic cells generated in serum-free conditions: regulation of soluble antigen uptake, apoptotic tumor cell phagocytosis, chemotaxis and T cell activation during maturation in vitro (Q73462113) (← links)
• Distinct subsets of dendritic cells resembling dermal DCs can be generated in vitro from monocytes, in the presence of different serum supplements (Q73661037) (← links)
• Differentiation of antigen-presenting cells (dendritic cells and macrophages) for therapeutic application in patients with lymphoma (Q74336550) (← links)
• PGE2 Is Crucial for the Generation of FAST Whole- Tumor-Antigens Loaded Dendritic Cells Suitable for Immunotherapy in Glioblastoma (Q90047227) (← links)
• Stem cell factor produced by tumor cells expands myeloid-derived suppressor cells in mice (Q97538757) (← links)